442-E A novel targeted, type I interferon producing, innate lymphocyte therapy with potent anti-tumor activityAnders Laustsen, Martin R. Jakobsen, Tobias Wang Bjerg et al.|Unknown|2023Cited by 0
417 Design of programmable immune reactive cells (PIRCs) with precision type I interferon and cytotoxicity response in solid tumorsAnders Laustsen, Martin R. Jakobsen, Lola Dachicourt et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0